BioAsia 2022: FABA to host special panel on challenges in building innovation in pharma sectors

New Delhi: Federation of Asian Biotech Associations (FABA) being at the forefront of promoting innovation and entrepreneurship in the biotech industry, academia, and healthcare sector is organizing a panel discussion as a part of BioAsia 2022 on “Challenges in building innovation engine in Pharma and biopharma sectors”.

The discussion will focus on proposing solutions to promote innovation in biotech and Pharma sectors, on 25th Feb at 9:30 am.

The session will be moderated by Uday Saxena, Co-founder and CEO ReaGene Innovations. The panelists who will share the stage are Ashwini Nangia, Professor, University of Hyderabad; Vinay Nandicoori, Director- CCMB; Satakarni Makkapati, President & Head, Biologics, Aurobindo Pharma; Gagandeep Kang, CMC Vellore (Former Director of THSTI); and Dr. Girish Krishnamurthy, CEO TATA medical and Diagnostics Ltd.

BioAsia 2022, hosted by Government of Telangana and supported by FABA, is all set to commence from 24th Feb with the theme ‘Future Ready’. This two-days event will focus on exploring pharma and healthcare industry current position and their future in light of novel approaches and capabilities beyond the pandemic.

BioAsia 2022 platform will be shared by leaders from the industry, academia, and governments from more than 70 countries to address the wide-ranging needs of the healthcare system.